JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

Search

Maravai LifeSciences Holdings Inc (Class A)

Cerrado

2.65 -1.12

Resumen

Variación precio

24h

Actual

Mínimo

2.65

Máximo

2.81

Métricas clave

By Trading Economics

Ingresos

-6.4M

-53M

Ventas

-9.6M

47M

Margen de beneficio

-112.813

Empleados

580

EBITDA

-28M

-49M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+71% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

95M

870M

Apertura anterior

3.77

Cierre anterior

2.65

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Maravai LifeSciences Holdings Inc (Class A) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 jul 2025, 21:15 UTC

Ganancias

Waste Management 2Q Profit and Sales Rise, Cuts Fiscal Year Sales Outlook

28 jul 2025, 23:48 UTC

Adquisiciones, fusiones, absorciones

Berkshire Hathaway Selling Part of Verisign Stake; Stock Falling After-Hours -- Barrons.com

28 jul 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Trade in Range Amid Uncertainty over Earnings -- Market Talk

28 jul 2025, 23:42 UTC

Ganancias

Keppel Pacific Oak US REIT: Property Expenses Rose on Year >CMOU.SG

28 jul 2025, 23:42 UTC

Charlas de Mercado

Gold Consolidates; Trade-Deal Hopes May Weigh -- Market Talk

28 jul 2025, 23:41 UTC

Ganancias

Keppel Pacific Oak US REIT 1H Income Available for Distribution $19.9M Vs. $23.8M >CMOU.SG

28 jul 2025, 23:40 UTC

Ganancias

Keppel Pacific Oak US REIT 1H Net Property Income $40.7M Vs. $42.0M >CMOU.SG

28 jul 2025, 23:40 UTC

Ganancias

Keppel Pacific Oak US REIT 1H Gross Rev $74.6M Vs. $74.4M >CMOU.SG

28 jul 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Woodside: Development Wells in Bass Strait Could Deliver Up to 200 PJ of Gas for Sale

28 jul 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Woodside Identifies 4 Potential Development Wells in Bass Strait

28 jul 2025, 23:35 UTC

Adquisiciones, fusiones, absorciones

Woodside Expects More Than US$60 Million of Savings From Bass Strait Operatorship

28 jul 2025, 23:34 UTC

Adquisiciones, fusiones, absorciones

Woodside to Pursue Strategy that Targets Further Output, Reliability Improvements in Bass Strait

28 jul 2025, 23:34 UTC

Adquisiciones, fusiones, absorciones

Woodside to Have Responsibility for Asset Planning, Execution Activities

28 jul 2025, 23:33 UTC

Adquisiciones, fusiones, absorciones

Woodside, Exxon Mobil's Equity Interests in Bass Strait Assets Unchanged

28 jul 2025, 23:32 UTC

Adquisiciones, fusiones, absorciones

Woodside Energy Expects to Complete Deal With Exxon Mobil in 2026

28 jul 2025, 23:32 UTC

Adquisiciones, fusiones, absorciones

Woodside Energy Agrees to Become Operator of Bass Strait Assets

28 jul 2025, 22:46 UTC

Charlas de Mercado

AIC Mines Bull Surprised by Capex Growth -- Market Talk

28 jul 2025, 22:29 UTC

Ganancias

Sandfire Resources to Provide FY26 Cost Guidance Alongside FY Results

28 jul 2025, 22:28 UTC

Ganancias

Sandfire Resources Expects FY26 Copper Eq Output of 149,000-165,000 Tons

28 jul 2025, 22:27 UTC

Ganancias

Sandfire Resources Net Debt US$123 Million at June 30

28 jul 2025, 22:27 UTC

Ganancias

Sandfire Resources FY Unaudited Underlying Ebitda US$528 Million

28 jul 2025, 22:26 UTC

Ganancias

Sandfire Resources FY Unaudited Sales Revenue US$1.18 Billion

28 jul 2025, 22:26 UTC

Ganancias

Sandfire Resources FY Motheo Underlying Operating Unit Cost US$40/Ton

28 jul 2025, 22:25 UTC

Ganancias

Sandfire Resources FY Matsa Underlying Operating Unit Cost US$78/Ton

28 jul 2025, 22:24 UTC

Ganancias

Sandfire Resources FY Copper Eq Output 152,400 Tons, Up 12% On-Year

28 jul 2025, 21:35 UTC

Ganancias

Lululemon Stock Has Rebounded. What to Expect From Earnings. -- Barrons.com

28 jul 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

LVMH-Backed L Catterton Strikes $200 Million Deal for L.A.B. Golf, Sources Say -- WSJ

28 jul 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

LVMH-Backed L Catterton to Buy Majority Stake After L.A.B. Golf's Putter Used to Win U.S. Open, Sources Say -- WSJ

28 jul 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

Private-Equity Firm L Catterton Strikes $200 Million Deal for L.A.B. Golf, Sources Say -- WSJ

28 jul 2025, 21:00 UTC

Ganancias

Waste Management 2Q Profit and Sales Rise, Cuts FY Sales Outlook

Comparación entre iguales

Cambio de precio

Maravai LifeSciences Holdings Inc (Class A) Esperado

Precio Objetivo

By TipRanks

71% repunte

Estimación a 12 meses

Media 4.6 USD  71%

Máximo 7 USD

Mínimo 2 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Maravai LifeSciences Holdings Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

4

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

2.02 / 2.115Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

No Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.